NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹26 Cr | ₹1,022 Cr | ₹973 Cr | ₹891 Cr | ₹1,004 Cr |
What is the latest Total Current Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹26 Cr |
| Mar2025 | ₹1,022 Cr |
| Mar2024 | ₹973 Cr |
| Mar2023 | ₹891 Cr |
| Mar2022 | ₹1,004 Cr |
How is Total Current Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹26 Cr | -97.45 | |
| Mar2025 | ₹1,022 Cr | 5.01 | |
| Mar2024 | ₹973 Cr | 9.19 | |
| Mar2023 | ₹891 Cr | -11.25 | |
| Mar2022 | ₹1,004 Cr | - | |
Compare Total Current Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹208.7 Cr | 0.8% | 4.3% | -29.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | 0.8% |
4.3% |
-29.7% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses